Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis

IntroductionChronic low-grade inflammation is an important aspect of morbidity and mortality in older adults. The level of circulating pro-inflammatory cytokines (interleukin (IL)-6, tumor necrosis factor (TNF) or IL-1β) is a risk factor in cardiovascular and neurodegenerative diseases and is also a...

Full description

Bibliographic Details
Main Authors: Anna Tylutka, Łukasz Walas, Agnieszka Zembron-Lacny
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1330386/full
_version_ 1797289750270312448
author Anna Tylutka
Łukasz Walas
Agnieszka Zembron-Lacny
author_facet Anna Tylutka
Łukasz Walas
Agnieszka Zembron-Lacny
author_sort Anna Tylutka
collection DOAJ
description IntroductionChronic low-grade inflammation is an important aspect of morbidity and mortality in older adults. The level of circulating pro-inflammatory cytokines (interleukin (IL)-6, tumor necrosis factor (TNF) or IL-1β) is a risk factor in cardiovascular and neurodegenerative diseases and is also associated with sarcopenia and frailties. The objective of this study was to assess each cytokine: IL-6, TNF, and IL-1β separately in the elderly with comorbidities against controls without diseases according to the data published in the available literature.MethodsThe electronic bibliographic PubMed database was systematically searched to select all the relevant studies published up to July 2023. The total number of the subjects involved in the meta-analysis included patients with diseases (n=8154) and controls (n=33967).ResultsThe overall concentration of IL-6 was found to be higher in patients with diseases compared to controls and the difference was statistically significant, with a p-value of <0.001 (SMD, 0.16; 95% CI, 0.12–0.19). The heterogeneity was considerable with Q = 109.97 (P <0.0001) and I2 = 79.2%. The potential diagnostic usefulness of IL-6 was confirmed by odds ratio (OR) analysis (OR: 1.03, 95% CI (1.01; 1.05), p=0.0029). The concentration of both TNF and IL-1β was elevated in the control group compared to patients and amounted to SMD -0.03; 95% CI, -0.09–0.02, p-value 0.533 and SMD-0.29; 95% CI, -0.47– -0.12; p = 0.001, respectively. For TNF, however, the difference was statistically insignificant.DiscussionIL-6, unlike TNF and IL-1β, could be a useful and convenient marker of peripheral inflammation in older adults with various comorbidities.
first_indexed 2024-03-07T19:10:31Z
format Article
id doaj.art-8cd7007ae3d8475587f5aa0cebbf50a5
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-07T19:10:31Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-8cd7007ae3d8475587f5aa0cebbf50a52024-03-01T04:45:21ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-03-011510.3389/fimmu.2024.13303861330386Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysisAnna Tylutka0Łukasz Walas1Agnieszka Zembron-Lacny2Department of Applied and Clinical Physiology, Collegium Medicum University of Zielona Gora, Zielona Gora, PolandInstitute of Dendrology, Polish Academy of Sciences, Kórnik, PolandDepartment of Applied and Clinical Physiology, Collegium Medicum University of Zielona Gora, Zielona Gora, PolandIntroductionChronic low-grade inflammation is an important aspect of morbidity and mortality in older adults. The level of circulating pro-inflammatory cytokines (interleukin (IL)-6, tumor necrosis factor (TNF) or IL-1β) is a risk factor in cardiovascular and neurodegenerative diseases and is also associated with sarcopenia and frailties. The objective of this study was to assess each cytokine: IL-6, TNF, and IL-1β separately in the elderly with comorbidities against controls without diseases according to the data published in the available literature.MethodsThe electronic bibliographic PubMed database was systematically searched to select all the relevant studies published up to July 2023. The total number of the subjects involved in the meta-analysis included patients with diseases (n=8154) and controls (n=33967).ResultsThe overall concentration of IL-6 was found to be higher in patients with diseases compared to controls and the difference was statistically significant, with a p-value of <0.001 (SMD, 0.16; 95% CI, 0.12–0.19). The heterogeneity was considerable with Q = 109.97 (P <0.0001) and I2 = 79.2%. The potential diagnostic usefulness of IL-6 was confirmed by odds ratio (OR) analysis (OR: 1.03, 95% CI (1.01; 1.05), p=0.0029). The concentration of both TNF and IL-1β was elevated in the control group compared to patients and amounted to SMD -0.03; 95% CI, -0.09–0.02, p-value 0.533 and SMD-0.29; 95% CI, -0.47– -0.12; p = 0.001, respectively. For TNF, however, the difference was statistically insignificant.DiscussionIL-6, unlike TNF and IL-1β, could be a useful and convenient marker of peripheral inflammation in older adults with various comorbidities.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1330386/fullcomorbiditiesimmunosenescenceinterleukin 1βinterleukin 6tumor necrosis factor
spellingShingle Anna Tylutka
Łukasz Walas
Agnieszka Zembron-Lacny
Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
Frontiers in Immunology
comorbidities
immunosenescence
interleukin 1β
interleukin 6
tumor necrosis factor
title Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
title_full Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
title_fullStr Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
title_full_unstemmed Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
title_short Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
title_sort level of il 6 tnf and il 1β and age related diseases a systematic review and meta analysis
topic comorbidities
immunosenescence
interleukin 1β
interleukin 6
tumor necrosis factor
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1330386/full
work_keys_str_mv AT annatylutka levelofil6tnfandil1bandagerelateddiseasesasystematicreviewandmetaanalysis
AT łukaszwalas levelofil6tnfandil1bandagerelateddiseasesasystematicreviewandmetaanalysis
AT agnieszkazembronlacny levelofil6tnfandil1bandagerelateddiseasesasystematicreviewandmetaanalysis